Throughout the duration of the project, we have established many workshops on biomedicine & hands-on practice for high school students based on our Platform of Aptamer-based Translational Medicine and Drug Discovery. Many high school students from Hong Kong SRA China, mainland China, United Kingdom, United States of America, and India participated in the workshops and published some research articles[a][b].
Fig Ed.1: Study Plan for the high-school biomedicine workshop.
For Hong Kong students, our workshop focused on topics relating to our project: aptamer discovery, technology development, and potential applications; osteogenesis imperfecta, sclerostin's functions and structures and our ostamer; as well as a brief introduction to microfluidics and its roles in aptamer development.
Fig. Ed.2: Article[1] written by one of our members on The Transcriptome, a blog dedicated to sharing science.
As part of a collaboration with iGEM Team Chalmers-Gothenburg,our members have written a guest article on the science blog The Transcriptome on our project. More details can be found here.
[a] Qing Ren, Duoli Xie, Yuanyuan Yu, Yuan Tang, Shuaijian Ni, Jun Lu, Aiping Lu, Ge Zhang, Sum Yee Chan, Bao-Ting Zhang. A potential next generation sclerostin inhibitor specifically targets sclerostin monomer for bone anabolic therapy with low cardiovascular risk in osteogenesis imperfecta mice. ASBMR 2019 Annual Meeting;1138. [b] Yuanyuan Yu, Qing Ren, Shuaijian Ni, Jin Liu, Chuanxin Zhong, Jun Lu, Dijie Li, Duoli Xie, Rongchen Dai, Huarui Zhang, Lei Dang, Aiping Lyu, Ge Zhang, Zhenjian Zhuo, Zong-Kang Zhang, Bao-Ting Zhang, Luyao Wang, Yongshu Li, Kui Kwan Wong, Joseph Zhai. A Potential Next Generation Sclerostin Inhibitor Specifically Targets Sclerostin Monomer for Bone Anabolic Therapy with Low Cardiovascular Risk to Reverse Established Osteoporosis in Ovariectomized Rats. ASBMR 2019 Annual Meeting; SUN-801. [1] Keung F (2021). "Osteogenesis Imperfecta: the Incurable Disorder".The Transcriptome.
